SCHEMBL27818541

SCHEMBL27818541

CC(C)(C[C@H]1CC[C@H](Nc2ncc(C#N)c(N)n2)CC1)OC(N)=O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 3/20 0.46
▸ MCHR1 Q99705 1/20 0.41
▸ MAPK8 P45983 3/20 0.39
▸ MAPK9 P45984 1/20 0.39
▸ CDK1 P06493 9/20 0.38
▸ CDK4 P11802 8/20 0.38
▸ CCND1 P24385 8/20 0.38
▸ CDK2 P24941 8/20 0.38
▸ CCNT1 O60563 1/20 0.37
▸ CCNB1 P14635 1/20 0.37
▸ CCNE1 P24864 1/20 0.37
▸ CCND3 P30281 1/20 0.37
▸ CDK7 P50613 1/20 0.37
▸ CDK9 P50750 1/20 0.37
▸ CCNH P51946 1/20 0.37
▸ MNAT1 P51948 1/20 0.37
▸ CDK6 Q00534 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ GNRHR P30968 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31524129 0.78 NPC1 (0.51) IRAK4CDK1CDK4CCND1CDK2
SCHEMBL3776834 0.76 NSD2 (0.49) IRAK4CDK1CDK4CCND1CDK2
SCHEMBL27818542 0.76 IRAK4 (0.45) IRAK4MAPK8MAPK9CDK1CDK4
SCHEMBL27735445 0.75 IRAK4 (0.44) IRAK4MAPK8MAPK9CDK1CDK4
SCHEMBL1936981 0.75 IRAK4 (0.46) IRAK4MCHR1MAPK8MAPK9CDK1
SCHEMBL1936977 0.75 IRAK4 (0.46) IRAK4MCHR1MAPK8MAPK9CDK1
SCHEMBL16671765 0.72 PIK3CD (0.49) IRAK4CDK1CDK4CCND1CDK2
SCHEMBL27796538 0.71 ALDH1A1 (0.43) MAPT
SCHEMBL13015069 0.70 CDK2 (0.47) IRAK4MAPK8CDK1CDK4CCND1
Hydrochloric Acid SCHEMBL3770686 0.69 CDK2 (0.46) IRAK4MAPK8CDK1CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102159547-A Heterocyclic carboxamide compounds ASTELLAS PHARMA INC 2011-08-17 — — CN disclosed
Send feedback